✦ LIBER ✦

Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer

✍ Scribed by Turpin, Elizabeth; Bièche, Ivan; Bertheau, Philippe; Plassa, Louis-François; Lerebours, Florence; de Roquancourt, Anne; Olivi, Martine; Espié, Marc; Marty, Michel; Lidereau, Rosette

Book ID: 110067075
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 178 KB
Volume: 21
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1205932

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Type of TP53 mutation and ERBB2 amplific

Type of TP53 mutation and ERBB2 amplification affects survival in node-negative breast cancer

✍ Hilmi Ozcelik; Dushanthi Pinnaduwage; Shelley B. Bull; Irene L. Andrulis 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 405 KB

c-erbB-2 protein overexpression and p53

c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues

✍ Shimizu, Chikako; Fukutomi, Takashi; Tsuda, Hitoshi; Akashi-Tanaka, Sadako; Wata 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

Background and Objectives: We investigated whether expression levels of c-erbB-2 and p53 proteins in breast cancer tissues differ in primary and metastatic lesions. Methods: Immunohistochemical staining or sandwich enzyme immunoassay was used to determine expression levels of c-erbB-2 and p53 protei

Germline TP53 mutations in BRCA1 and BRC

Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families

✍ Suzanna L. Arcand; Christine M. Maugard; Parviz Ghadirian; André Robidoux; Chant 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 204 KB

Increased frequency of TP53 mutations in

Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours

✍ Susan J. Ramus; Lynda G. Bobrow; Paul D.P. Pharoah; Damon S. Finnigan; Ami Fishm 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

We screened 81 ovarian tumours (30 BRCA1 associated, 18 BRCA2 associated, and 33 sporadic) for somatic TP53 mutations using both DNA analysis and immunostaining. TP53 mutations were significantly more frequent in tumours with mutations in BRCA1 (70% by immunostaining and 60% by DNA analysis) and BRC

Overexpression of ErbB2 in the exocrine

Overexpression of ErbB2 in the exocrine pancreas induces an inflammatory response but not increased proliferation

✍ Hana Algül; Martin Wagner; Marina Lesina; Roland M. Schmid 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 834 KB

## Abstract Tyrosine kinase receptors such as members of the epidermal growth factor receptor family and their respective ligands are frequently overexpressed in pancreatic cancer as well as in chronic pancreatitis. In this study, the role of ErbB2 in the exocrine pancreas was examined by ectopic o

Low incidence of BRCA2 mutations in brea

Low incidence of BRCA2 mutations in breast carcinoma and other cancers

✍ Teng, David H.-R; Bogden, Robert; Mitchell, Jeffrey; Baumgard, Michelle; Bell, R 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 361 KB